Poniard Pharmaceuticals Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Poniard Pharmaceuticals Inc은 수익성이 있나요?
Poniard Pharmaceuticals Inc에 부채가 있나요?
Poniard Pharmaceuticals Inc의 발행 주식은 몇 주인가요?
주요 통계
이전 종가
$0.0001
시가
$0.0001
일일 범위
$0.0001 - $0.0001
52주 범위
$0.0001 - $0.0001
거래량
7
평균 거래량
161
EPS(TTM)
-11.78
배당수익률
--
시가총액
$150
PARD란 무엇인가요?
Poniard Pharmaceuticals, Inc. is a bio-pharmaceutical company, which focuses on the development and commercialization of oncology products. The company is headquartered in Seattle, Washington and currently employs 7 full-time employees. The company went IPO on 2011-12-30. The firm focuses on the development and commercialization of oncology products to impact the lives of people with cancer. The company develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The firm has offices in San Francisco, California; and Seattle, Washington in United States.